Park Ha Biological Technology (BYAH) Registration filing summary

Company overview and business model

• Operates as a Cayman Islands holding company with business conducted through PRC subsidiaries and VIEs in China, focusing on proprietary skincare products and franchise alliances under the “Park Ha” brand.

• Product line includes nearly 70 skincare products, with a focus on small molecule peptide compositions for sensitive skin.

• Franchise network spans multiple provinces in China, with direct sales, franchise promotions, and after-sales beauty services.

• Growth strategies include expanding R&D, vocational training, social media marketing, supply chain partnerships, and strategic acquisitions.

Financial performance and metrics

• As of April 15, 2026, public float was approximately $5.14 million, based on 4,510,446 Class A Ordinary Shares held by non-affiliates at $1.14 per share.

• In August 2025, $1.4 million was transferred from the holding company to a PRC subsidiary; no dividends or other cash transfers to investors as of the prospectus date.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for business expansion, including the opening of directly operated stores in China.

• No anticipated cash dividends in the foreseeable future; funds and earnings are intended to be retained for operations and growth.